Company news
Shanghai Haohai Biological Technology Co., Ltd. news in 2026
Shanghai Haohai Biological Technology Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(688366)"Shanghai Haohai Biological Technology Co., Ltd."Announcement on Use of Temporarily Idle Raised Funds for Cash Management
November 2, 2026
(688366)"Shanghai Haohai Biological Technology Co., Ltd."Report for Q3 2026
October 23, 2026
Announcement on Adjustment of the Total Cash Dividend Amount for the 2026 Semi-annual Profit Distribution
September 13, 2026
Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
September 7, 2026
Announcement on the Profit Distribution Plan for the First Half of 2026
August 21, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Trifocal Toric Intraocular Lens Product of the Controlled Subsidiary
August 6, 2026
Announcement on the Cancellation of Repurchased H Shares
June 22, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 10, 2026
Announcement on Voluntary Disclosure of the Holding Subsidiary’s Trifocal Intraocular Lens Product Obtaining the Medical Device Registration Certificate
June 2, 2026
Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
June 1, 2026
Announcement on Notifying Creditors in Connection with the Repurchase of H-share Stocks
May 29, 2026
Announcement on Result of Shareholding Reduction by Shareholder
May 25, 2026
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
April 30, 2026
Notice on Convening the 2025 Annual General Meeting, the 1st Shareholders' Meeting of A Shares of 2026 and the 1st Shareholders' Meeting of H Shares of 2026
April 28, 2026
Report for Q1 2026
April 24, 2026
Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Multifocal Aspherical Intraocular Lens Product Obtaining the Medical Device Registration Certificate
April 7, 2026
Announcement on Provision for Asset Impairment for 2025
March 20, 2026
Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate
March 16, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Shareholding Reduction Plan for Shareholders
February 12, 2026